Cite
Recombinant human erythropoietin attenuates weight loss in a murine cancer cachexia model.
MLA
van Halteren, H. K., et al. “Recombinant Human Erythropoietin Attenuates Weight Loss in a Murine Cancer Cachexia Model.” Journal of Cancer Research & Clinical Oncology, vol. 130, no. 4, Apr. 2004, pp. 211–16. EBSCOhost, https://doi.org/10.1007/s00432-003-0526-7.
APA
van Halteren, H. K., Bongaerts, G. P. A., Verhagen, C. A. M., Kamm, Y. J. L., Willems, J. L., Grutters, G. J., Koopman, J. P., & Wagener, D. J. T. (2004). Recombinant human erythropoietin attenuates weight loss in a murine cancer cachexia model. Journal of Cancer Research & Clinical Oncology, 130(4), 211–216. https://doi.org/10.1007/s00432-003-0526-7
Chicago
van Halteren, H.K., G.P.A. Bongaerts, C.A.M. Verhagen, Y.J.L. Kamm, J.L. Willems, G.J. Grutters, J.P. Koopman, and D.J.Th. Wagener. 2004. “Recombinant Human Erythropoietin Attenuates Weight Loss in a Murine Cancer Cachexia Model.” Journal of Cancer Research & Clinical Oncology 130 (4): 211–16. doi:10.1007/s00432-003-0526-7.